NOS2 and periodontitis: Mercaptoethylguanidine (MEG), a selective inhibitor of iNOS and a scavenger of peroxynitrite,[19] was shown to significantly reduce plasma extravasation in gingivomucosal tissue, and decrease the degree of alveolar bone destruction in a rat model of periodontitis.